T2C2 Capital

Summary

The main department of described VC is located in the Montru00e9al. The venture was found in North America in Canada.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the T2C2 Capital, startups are often financed by Pitango Venture Capital, GeneChem, Canadian Medical Discoveries Fund. The meaningful sponsors for the fund in investment in the same round are Desjardins Venture Capital, Business Development Bank of Canada, Fonds de solidaritu00e9 FTQ. In the next rounds fund is usually obtained by VenGrowth Asset Management, Desjardins Venture Capital, Caisse de Depot et Placement du Quebec.

Among the various public portfolio startups of the fund, we may underline Enobia Pharma, Cytochroma, Interomex BioPharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular fund investment industries, there are Biopharma, Analytics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The top amount of exits for fund were in 2013. The real fund results show that this VC is 11 percentage points less often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2005. Opposing the other organizations, this T2C2 Capital works on 16 percentage points more the average amount of lead investments.